These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 29944388)
1. β-Klotho deficiency shifts the gut-liver bile acid axis and induces hepatic alterations in mice. Somm E; Henry H; Bruce SJ; Bonnet N; Montandon SA; Niederländer NJ; Messina A; Aeby S; Rosikiewicz M; Fajas L; Sempoux C; Ferrari SL; Greub G; Pitteloud N Am J Physiol Endocrinol Metab; 2018 Nov; 315(5):E833-E847. PubMed ID: 29944388 [TBL] [Abstract][Full Text] [Related]
2. β-Klotho deficiency protects against obesity through a crosstalk between liver, microbiota, and brown adipose tissue. Somm E; Henry H; Bruce SJ; Aeby S; Rosikiewicz M; Sykiotis GP; Asrih M; Jornayvaz FR; Denechaud PD; Albrecht U; Mohammadi M; Dwyer A; Acierno JS; Schoonjans K; Fajas L; Greub G; Pitteloud N JCI Insight; 2017 Apr; 2(8):. PubMed ID: 28422755 [TBL] [Abstract][Full Text] [Related]
3. Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation. Rau M; Stieger B; Monte MJ; Schmitt J; Jahn D; Frey-Wagner I; Raselli T; Marin JJ; Müllhaupt B; Rogler G; Geier A Inflamm Bowel Dis; 2016 Oct; 22(10):2382-9. PubMed ID: 27580383 [TBL] [Abstract][Full Text] [Related]
4. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho. Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice. Brooks NE; Hjortebjerg R; Henry BE; List EO; Kopchick JJ; Berryman DE Growth Horm IGF Res; 2016; 30-31():22-30. PubMed ID: 27585733 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity. Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091 [TBL] [Abstract][Full Text] [Related]
7. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Degirolamo C; Rainaldi S; Bovenga F; Murzilli S; Moschetta A Cell Rep; 2014 Apr; 7(1):12-8. PubMed ID: 24656817 [TBL] [Abstract][Full Text] [Related]
8. N-3 polyunsaturated fatty acids increase hepatic fibroblast growth factor 21 sensitivity via a PPAR-γ-β-klotho pathway. Yang W; Chen X; Liu Y; Chen M; Jiang X; Shen T; Li Q; Yang Y; Ling W Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28371258 [TBL] [Abstract][Full Text] [Related]
9. Capsaicin Improves Glucose Tolerance and Insulin Sensitivity Through Modulation of the Gut Microbiota-Bile Acid-FXR Axis in Type 2 Diabetic db/db Mice. Hui S; Liu Y; Chen M; Wang X; Lang H; Zhou M; Yi L; Mi M Mol Nutr Food Res; 2019 Dec; 63(23):e1900608. PubMed ID: 31539192 [TBL] [Abstract][Full Text] [Related]
10. Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling. Yan S; Khambu B; Chen X; Dong Z; Guo G; Yin XM Cell Mol Gastroenterol Hepatol; 2021; 11(4):973-997. PubMed ID: 33127558 [TBL] [Abstract][Full Text] [Related]
11. Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue. Asrih M; Altirriba J; Rohner-Jeanrenaud F; Jornayvaz FR PLoS One; 2015; 10(5):e0126364. PubMed ID: 25973847 [TBL] [Abstract][Full Text] [Related]
12. Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice. Maekawa R; Seino Y; Ogata H; Murase M; Iida A; Hosokawa K; Joo E; Harada N; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Hayashi Y; Arima H J Nutr Biochem; 2017 Nov; 49():71-79. PubMed ID: 28886439 [TBL] [Abstract][Full Text] [Related]
13. Glucagon receptor signaling regulates weight loss via central KLB receptor complexes. Nason SR; Antipenko J; Presedo N; Cunningham SE; Pierre TH; Kim T; Paul JR; Holleman C; Young ME; Gamble KL; Finan B; DiMarchi R; Hunter CS; Kharitonenkov A; Habegger KM JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33411693 [TBL] [Abstract][Full Text] [Related]
14. Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 Action. Zhang J; Gupte J; Gong Y; Weiszmann J; Zhang Y; Lee KJ; Richards WG; Li Y EBioMedicine; 2017 Feb; 15():173-183. PubMed ID: 28041926 [TBL] [Abstract][Full Text] [Related]
15. Liver-secreted FGF21 induces sarcopenia by inhibiting satellite cell myogenesis via klotho beta in decompensated cirrhosis. Zhou D; Shi Y; Zhang D; Zuo J; Zeng C; Mamtawla G; Huang L; Gao X; Zhang L; Wang X Redox Biol; 2024 Oct; 76():103333. PubMed ID: 39226764 [TBL] [Abstract][Full Text] [Related]
16. Relevant use of Klotho in FGF19 subfamily signaling system in vivo. Tomiyama K; Maeda R; Urakawa I; Yamazaki Y; Tanaka T; Ito S; Nabeshima Y; Tomita T; Odori S; Hosoda K; Nakao K; Imura A; Nabeshima Y Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1666-71. PubMed ID: 20080590 [TBL] [Abstract][Full Text] [Related]
17. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway. Díaz-Delfín J; Hondares E; Iglesias R; Giralt M; Caelles C; Villarroya F Endocrinology; 2012 Sep; 153(9):4238-45. PubMed ID: 22778214 [TBL] [Abstract][Full Text] [Related]
18. FGF15 improves outcomes after brain dead donor liver transplantation with steatotic and non-steatotic grafts in rats. Gulfo J; Rotondo F; Ávalos de León CG; Cornide-Petronio ME; Fuster C; Gracia-Sancho J; Jiménez-Castro MB; Peralta C J Hepatol; 2020 Nov; 73(5):1131-1143. PubMed ID: 32422221 [TBL] [Abstract][Full Text] [Related]
20. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis. Schumacher JD; Kong B; Pan Y; Zhan L; Sun R; Aa J; Rizzolo D; Richardson JR; Chen A; Goedken M; Aleksunes LM; Laskin DL; Guo GL Toxicol Appl Pharmacol; 2017 Sep; 330():1-8. PubMed ID: 28673684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]